The DOI matches its Crossref record; 158 of the 159 references it cites were found in a registry or an index.
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Abstract
Tissue hypoxia results from an inadequate supply of oxygen (O(2)) that compromises biologic functions. Evidence from experimental and clinical studies increasingly points to a fundamental role for hypoxia in solid tumors. Hypoxia in tumors is primarily a pathophysiologic consequence of structurally and functionally disturbed microcirculation and the deterioration of diffusion conditions. Tumor hypoxia appears to be strongly associated with tumor propagation, malignant progression, and resistance to therapy, and it has thus become a central issue in tumor physiology and cancer treatment. Biochemists and clinicians (as well as physiologists) define hypoxia differently; biochemists define it as O(2)-limited electron transport, and physiologists and clinicians define it as a state of reduced O(2) availability or decreased O(2) partial pressure that restricts or even abolishes functions of organs, tissues, or cells. Because malignant tumors no longer execute functions necessary for homeostasis (such as the production of adequate amounts of adenosine triphosphate), the physiology-based definitions of the term "hypoxia" are not necessarily valid for malignant tumors. Instead, alternative definitions based on clinical, biologic, and molecular effects that are observed at O(2) partial pressures below a critical level have to be applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
(1989) · PubMed · Cited by 3,343
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,891
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Self-citation
Research works printed but not linked: 35
- Brown, 1998, Cancer Research, 58, 1408
- Hockel, 1996, Cancer Research, 56, 4509
- Brizel, 1996, Cancer Research, 56, 941
- Walenta, 2000, Cancer Research, 60, 916
- Hockel, 1999, Cancer Research, 59, 4525
- Kim, 1997, Cancer Research, 57, 4200
- Anthoney, 1996, Cancer Research, 56, 1374
- Vaupel, 1989, Cancer Research, 49, 6449
- Vaupel, 1987, Cancer Research, 47, 3496
- Kallinowski, 1989, Cancer Research, 49, 3759
- 1973, Advances in experimental medicine and biology, 37, 277
- Vaupel, 1991, Cancer Research, 51, 3316
- Hockel, 1991, Cancer Research, 51, 6098
- Wilson, 1992, Cancer Research, 52, 3988
- 1996, BRITISH JOURNAL OF CANCER, 74, S226
- Valk, 1992, Journal of Nuclear Medicine, 33, 2133
- Groshar, 1993, Journal of Nuclear Medicine, 34, 885
- Lord, 1993, Cancer Research, 53, 5721
- Evans, 1996, Cancer Research, 56, 405
- Riva, 1998, Anticancer Research, 18, 4729
- Prehn, 1991, Cancer Research, 51, 2
- Ausserer, 1994, Molecular and Cellular Biology, 14, 5032, 10.1128/mcb.14.8.5032 · DOI
- Hartmann, 1999, Cancer Research, 59, 1578
- Koong, 1994, Cancer Research, 54, 1425
- Henderson, 1987, Cancer Research, 47, 3110
- Mitchell, 1985, Cancer Research, 45, 2008
- Reynolds, 1996, Cancer Research, 56, 5754
- Stoler, 1992, Cancer Research, 52, 4372
- Russo, 1995, Cancer Research, 55, 1122
- Teicher, 1990, Cancer Research, 50, 3339
- Teicher, 1981, Cancer Research, 41, 73
- Moan, 1985, Cancer Research, 45, 1608
- 1981, Bibliotheca anatomica, 20, 628
- 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 46, S107
- 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48, S162
Cited by
Sorted by citations
Items 401–500 of 1,008
Functional imaging of intratumoral hypoxia
Foo, S. S., Abbott, D. F., Lawrentschuk, N., & Scott, A. M. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.06.007 · Cited by 109
Sauvant, C., Nowak, M., Wirth, C., Schneider, B., Riemann, A., Gekle, M., & Thews, O. (2008) · International Journal of Cancer · doi:10.1002/ijc.23818 · Cited by 109
The Different Routes to Metastasis via Hypoxia-Regulated Programs
Nobre, A. R., Entenberg, D. R., Wang, Y., Condeelis, J. S., & Aguirre‐Ghiso, J. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.008 · Cited by 106
Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice
Matsumoto, S., Hyodo, F., Subramanian, S., Devasahayam, N., Munasinghe, J., Hyodo, E., Gadisetti, C., Cook, J. A., Mitchell, J. B., & Krishna, M. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34928 · Cited by 112
Edsjö, A., Mengelbier, L. H., & Påhlman, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.04.005 · Cited by 110
Erapaneedi, R., Belousov, V. V., Schäfers, M. A., & Kiefer, F. (2015) · The EMBO Journal · doi:10.15252/embj.201592775 · Cited by 114
Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication
Foskolou, I. P., Jorgensen, C., Leszczyńska, K. B., Olcina, M. M., Tarhonskaya, H., Haisma, B., D’Angiolella, V., Myers, W. K., Domene, C., Flashman, E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.005 · Cited by 110
Measuring Changes in Tumor Oxygenation
Zhao, D., Jiang, L., & Mason, R. P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)86018-x · Cited by 108
Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation
An, J., Mo, D., Liu, H., Veena, M. S., Srivatsan, E. S., Massoumi, R., & Rettig, M. B. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.007 · Cited by 115
Hypoxia Helps Glioma to Fight Therapy
Murphy, V. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166637 · Cited by 111
Hypoxia Induces Proteasome-Dependent Degradation of Estrogen Receptor α in ZR-75 Breast Cancer Cells
Stoner, M. A., Saville, B., Wormke, M., Dean, D. D., Burghardt, R. C., & Safe, S. H. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0347 · Cited by 105
Huang, W., Chiang, W., Cheng, Y., Lin, W.-C., Yu, C., Yen, C.-Y., Yeh, C., Chern, C., Chiang, C., & Chiu, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.033 · Cited by 107
Li, S., Xie, B., Cheng, H. B., Li, C., Zhang, M., Qiu, W., Liu, W., Wang, X., & Zhang, X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.021 · Cited by 109
Park, J. Y., Sung, J., Lee, J.-H., Park, Y.-K., Kim, Y. W., Kim, G. Y., Won, K. Y., & Lim, S. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.09.005 · Cited by 106
Jeong, J., Gurunathan, S., Kang, M.-H., Han, J. W., Das, J., Choi, Y., Kwon, D., Cho, S., Park, C., Seo, H. G., et al. (2016) · Scientific Reports · doi:10.1038/srep21688 · Cited by 107
Walenta, S., Chau, T.-V., Schroeder, T., Lehr, H., Kunz‐Schughart, L. A., Fuerst, A., & Mueller‐Klieser, W. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0450-x · Cited by 106
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy- d -glucose
Maher, J. C., Wangpaichitr, M., Savaraj, N., Kurtoğlu, M., & Lampidis, T. J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0407 · Cited by 107
NDRG2 is a new HIF-1 Target Gene Necessary for Hypoxia-Induced Apoptosis in A549 Cells
Wang, L., Liu, N., Yao, L., Li, F., Zhang, J., Deng, Y., Liu, J., Ji, S., Yang, A., Han, H., et al. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000113765 · Cited by 106
Tumor-specific gene expression using the survivin promoter is further increased by hypoxia
Li, Y., Cao, Z., Li, F., Post, D. E., Meir, E. G. V., Zhong, H., & Wood, W. C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302280 · Cited by 109
Increase in the photoreactivity of uracil derivatives by doubling thionation
Pollum, M., Jockusch, S., & Crespo‐Hernández, C. E. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp04822b · Cited by 106
The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells
Guan, G., Zhang, Y., Lu, Y. W., Liu, L., Shi, D., Wen, Y., Yang, L., Ma, Q., Liu, T., Zhu, X., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.034 · Cited by 106
Yeo, C. D., Kang, N., Choi, S. Y., Kim, B. N., Park, C. K., Kim, J. W., Kim, Y. K., & Kim, S. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.302 · Cited by 109
Sensitization of Hypoxic Tumors to Radiation Therapy Using Ultrasound-Sensitive Oxygen Microbubbles
Eisenbrey, J. R., Shraim, R., Liu, J., Li, J., Stanczak, M., Oeffinger, B. E., Leeper, D. B., Keith, S. W., Delaney, L. J., Forsberg, F., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.042 · Cited by 107
Puri, S., & Juvale, K. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112393 · Cited by 115
What is the malignant nature of human ductal carcinoma in situ?
Espina, V. A., & Liotta, L. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2950 · Cited by 110
Minchenko, О. H., Ochiai, A., Opentanova, I., Ogura, T., Minchenko, D. O., Caro, J., Комісаренко, С. В., & Esumi, H. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.007 · Cited by 102
Tomiyama, A., Serizawa, S., Tachibana, K., Sakurada, K., Samejima, H., Kuchino, Y., & Kitanaka, C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj395 · Cited by 106
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
Myszczyszyn, A., Czarnecka, A. M., Matak, D., Szymański, Ł., Lian, F., Kornakiewicz, A., Bartnik, E., Kukwa, W., Kiéda, C., & Szczylik, C. A. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9611-y · Cited by 109
PET of Hypoxia with89Zr-Labeled cG250-F(ab′)2in Head and Neck Tumors
Hoeben, B. A. W., Kaanders, J. H. A. M., Franssen, G. M., Troost, E. G. C., Rijken, P. F. J. W., Oosterwijk, E., van Dongen, G. A. M. S., Oyen, W. J. G., Boerman, O. C., & Bussink, J. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073189 · Cited by 103
An, L., Wang, Y., Lin, J., Tian, Q., Xie, Y., Hu, J., & Yang, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b00495 · Cited by 105
Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
Sun, H., Wang, S. L., Yan, S., Zhang, Y., Nelson, P. J., Jia, H., Qin, L., & Dong, Q. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01104 · Cited by 109
Aptamer-Targeted Photodynamic Platforms for Tumor Therapy
Yan, J., Gao, T., Lu, Z., Yin, J., Zhang, Y., & Pei, R. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06818 · Cited by 107
Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma
Al‐Ahmadie, H. A., Alden, D., Qin, L., et al. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181570343 · Cited by 103
Lack of Hypoxic Response in Uterine Leiomyomas despite Severe Tissue Hypoxia
Mayer, A., Höckel, M., Wree, A., Leo, C., Horn, L., & Vaupel, P. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6339 · Cited by 107
Self-citationThe role of proton dynamics in the development and maintenance of multidrug resistance in cancer
Daniel, C., Bell, C., Burton, C., Harguindey, S., Reshkin, S. J., & Rauch, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.020 · Cited by 105
Chen, H., Aggarwal, R. R., Bok, R., Ohliger, M. A., Zhu, Z., Lee, P., Gordon, J. W., Criekinge, M. V., Carvajal, L. E., Slater, J. B., et al. (2019) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-019-0180-z · Cited by 105
Yu, W., Lin, R., He, X., Yang, X., Zhang, H., Hu, C., Liu, R., Huang, Y., Qin, Y., & Gao, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.006 · Cited by 105
Ide, T., Kitajima, Y., Miyoshi, A., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9435-3 · Cited by 102
Okuyama, H., Endo, H., Akashika, T., Kato, K., & Inoue, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2720 · Cited by 103
Wan, X., Li, W., Li, H., Dong, M., Lin, Q., Ma, X.-K., Huang, P., Wen, J.-Y., Li, X., Chen, J., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.008 · Cited by 99
Engineering Nanoparticles for Optimized Photodynamic Therapy
Dai, X., Du, T., & Han, K. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01251 · Cited by 103
Mayer, A., Wree, A., Höckel, M., Leo, C., Pilch, H., & Vaupel, P. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3566 · Cited by 101
Self-citationHarada, H., Kizaka‐Kondoh, S., & Hiraoka, M. (2005) · Molecular Imaging · doi:10.1162/15353500200505112 · Cited by 103
Yan, W., Fu, Y., Tian, D., Liao, J., Liu, M., Wang, B., Xia, L., Zhu, Q., & Luo, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.088 · Cited by 100
Bilton, R. L., Mazure, N. M., Trottier, E., Hattab, M., Déry, M.-A. C., Richard, D. E., Pouysségur, J., & Brahimi-Horn, M. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504482200 · Cited by 101
Vaupel, P. W., Mayer, A., Briest, S., & Höckel, M. (2003) · PubMed · Cited by 100
Self-citationHypoxia-induced and stress-specific changes in chromatin structure and function
Johnson, A. B., & Barton, M. C. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.10.007 · Cited by 104
Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer
Yuh, W. T. C., Mayr, N. A., Jarjoura, D. G., et al. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181a64ce9 · Cited by 99
HIF1α-associated circDENND4C Promotes Proliferation of Breast Cancer Cells in Hypoxic Environment
Liang, G., Liu, Z., Tan, L., Su, A. N., Jiang, W. G., & Gong, C. (2017) · Anticancer Research · doi:10.21873/anticanres.11827 · Cited by 99
Krause, N., & Wegner, A. (2020) · Cells · doi:10.3390/cells9122635 · Cited by 103
Yang, M., Ma, C., Liu, S., Sun, J., Shao, Q., Gao, W., Zhang, Y., Li, Z., Xie, Q., Dong, Z., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02954.x · Cited by 99
Anticancer nanoparticulate polymer‐drug conjugate
Feng, Q., & Tong, R. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10033 · Cited by 99
Zhao, Y., He, P., Yao, J., Li, M., Wang, B., Han, L., Huang, Z., Guo, C., Bai, J., Xue, F., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122237 · Cited by 101
Near-infrared uncaging or photosensitizing dictated by oxygen tension
Anderson, E. D., Gorka, A. P., & Schnermann, M. J. (2016) · Nature Communications · doi:10.1038/ncomms13378 · Cited by 99
Hoogsteen, I. J., Marres, H. A. M., Bussink, J., van der Kogel, A. J., & Kaanders, J. H. A. M. (2007) · Head & Neck · doi:10.1002/hed.20543 · Cited by 100
Nam, S.-Y., Ko, Y. S., Jung, J. H., Yoon, J., Kim, Y. H., Choi, Y. J., Park, J.-W., Chang, M. S., Kim, W. H., & Lee, B. L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606020 · Cited by 97
Imaging tumor hypoxia by magnetic resonance methods
Pacheco‐Torres, J., López‐Larrubia, P., Ballesteros, P., & Cerdán, S. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1558 · Cited by 99
Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma
Nakashiro, K. (2009) · Oncology Reports · doi:10.3892/or_00000275 · Cited by 99
Guo, X., Qu, J., Zhu, C., Li, W., Luo, L., Yang, J., Yin, X., Li, Q., Du, Y., Chen, D., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435751 · Cited by 101
Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia
Berger, A. P., Kofler, K., Bektić, J., Rogatsch, H., Steiner, H., Bartsch, G. H., & Klocker, H. (2003) · The Prostate · doi:10.1002/pros.10279 · Cited by 97
Oxygen-Controlled Three-Dimensional Cultures to Analyze Tumor Angiogenesis
Verbridge, S. S., Choi, N., Zheng, Y. Y., Brooks, D. J., Stroock, A. D., & Fischbach, C. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0670 · Cited by 99
Anderson, C. J., Hoare, S. F., Ashcroft, M. A., Bilsland, A. E., & Keith, W. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209011 · Cited by 96
Microfluidic oxygen imaging using integrated optical sensor layers and a color camera
Ungerböck, B., Charwat, V., Ertl, P., & Mayr, T. (2013) · Lab on a Chip · doi:10.1039/c3lc41315b · Cited by 96
Benjaminsen, I. C., Graff, B. A., Brurberg, K. G., et al. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20149 · Cited by 96
RETRACTED: HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
Maroni, P., Bendinelli, P., Matteucci, E., & Desiderio, M. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl129 · Cited by 96
RetractedNanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Pan, Y., Liu, L., Mou, X., & Cai, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c07763 · Cited by 98
Jonathan, R. A., Wijffels, K. I. E. M., Peeters, W. J. M., de Wilde, P. C. M., Marres, H. A. M., Merkx, M. A. W., Oosterwijk, E., van der Kogel, A. J., & Kaanders, J. H. A. M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.04.008 · Cited by 95
Arcasoy, M. O., Amin, K., Chou, S.-C., Haroon, Z. A., Varia, M. A., & Raleigh, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.20.11.1 · Cited by 95
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Minchenko, О. H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13705 · Cited by 96
Demir, I., Tieftrunk, E., Schorn, S., Saricaoglu, Ö. C., Pfitzinger, P., Teller, S., Wang, K., Waldbaur, C., Kurkowski, M. U., Wörmann, S., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309784 · Cited by 85
Imaging Tumor Hypoxia to Advance Radiation Oncology
Lee, C.-T., Boss, M., & Dewhirst, M. W. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5759 · Cited by 98
Bobarykina, A. Y., Minchenko, D. O., Opentanova, I. L., Moenner, M., Caro, J., Esumi, H., & Minchenko, О. H. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3308 · Cited by 96
Schietroma, M., Cecilia, E. M., Carlei, F., Sista, F., De Santis, G., Piccione, F., & Amicucci, G. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2714-7 · Cited by 92
Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents
Ortiz‐Rodríguez, L. A., & Crespo‐Hernández, C. E. (2020) · Chemical Science · doi:10.1039/d0sc04747c · Cited by 95
Hypoxia-Activated PEGylated Paclitaxel Prodrug Nanoparticles for Potentiated Chemotherapy
Hao, D., Meng, Q., Jiang, B., Lu, S., Xiang, X., Pei, Q., Yu, H., Jing, X., & Xie, Z. (2022) · ACS Nano · doi:10.1021/acsnano.2c05341 · Cited by 93
A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment
Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0006-3 · Cited by 96
Wenzl, T., & Wilkens, J. J. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-171 · Cited by 93
Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer
Li, Y., Zhang, D., Wang, X., Yao, X., Cheng, Y., Zhang, S., Wang, H., Chang, C., Xia, H., Wang, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12495 · Cited by 94
Kasashima, H., Yashiro, M., Kinoshita, H., Fukuoka, T., Morisaki, T., Masuda, G., Sakurai, K., Kubo, N., Ohira, M., & Hirakawa, K. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0510-3 · Cited by 92
Barthel, H., Wilson, H., Collingridge, D. R., Brown, G. D., Osman, S., Luthra, S. K., Brady, F., Workman, P., Price, P., & Aboagye, E. O. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601862 · Cited by 98
Nagpal, N., Ahmad, H. M., Chameettachal, S., Sundar, D., Ghosh, S., & Kulshreshtha, R. (2015) · Scientific Reports · doi:10.1038/srep09650 · Cited by 94
Tumor Volume and Tumor Hypoxia in Head and Neck Cancers
Dunst, J., Stadler, P. F., Becker, A., et al. (2003) · Strahlentherapie und Onkologie · doi:10.1007/s00066-003-1066-4 · Cited by 92
Src-mediated regulation of E-cadherin and EMT in pancreatic cancer
Nagathihalli, N. S. (2012) · Frontiers in bioscience · doi:10.2741/4037 · Cited by 90
A biomimetic 3D model of hypoxia-driven cancer progression
Liverani, C., Vita, A. D., Minardi, S., Kang, Y., Mercatali, L., Amadori, D., Bongiovanni, A., Manna, F. L., Ibrahim, T., & Tasciotti, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-48701-4 · Cited by 95
The Molecular Adaptive Responses of Skeletal Muscle to High-Intensity Exercise/Training and Hypoxia
Li, J., Li, Y., ATAKAN, M. M., Kuang, J., Hu, Y., Bishop, D. J., & Yan, X. (2020) · Antioxidants · doi:10.3390/antiox9080656 · Cited by 99
Wang, W., Liu, X., Zheng, X., Jin, H. J., & Li, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001117 · Cited by 92
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 92
Activity of Psoralen-Functionalized Nanoscintillators against Cancer Cells upon X-ray Excitation
Scaffidi, J. P., Gregas, M. K., Lauly, B., Zhang, Y., & Vo‐Dinh, T. (2011) · ACS Nano · doi:10.1021/nn200511m · Cited by 90
Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer
Schito, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_5 · Cited by 93
Calvani, M., Comito, G., Giannoni, E., & Chiarugi, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038388 · Cited by 92
Interactions Between Hypoxia and Epidermal Growth Factor Receptor in Non–Small-Cell Lung Cancer
Swinson, D., & O'Byrne, K. J. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.002 · Cited by 91
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression
Pipiya, T., Sauthoff, H., Huang, Y., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302459 · Cited by 90
Zhu, Q., Tannenbaum, S. H., Hegde, P., et al. (2008) · Neoplasia · doi:10.1593/neo.08602 · Cited by 89
Carnell, D. M., Smith, R. E., Daley, F. M., Saunders, M. I., Bentzen, S. M., & Hoskin, P. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.11.044 · Cited by 89
Liu, X., Zhang, K., Gao, J., Chen, Y., Tung, C., & Wu, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202007039 · Cited by 88
Transcriptional and posttranscriptional regulation of the plasminogen activator system
Medcalf, R. L., Muñoz‐Cánoves, P., & Nagamine, Y. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0814 · Cited by 90
Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma
Li, M., Gu, Y., Zhang, Z., et al. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9220-7 · Cited by 88
The Hypoxia-Inducible Factor and Tumor Progression Along the Angiogenic Pathway
Brahimi-Horn, M. C., & Pouysségur, J. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42004-x · Cited by 87
C‐type lectin domain group 14 proteins in vascular biology, cancer and inflammation
Khan, K. A., McMurray, J. L., Mohammed, F., & Bicknell, R. (2019) · FEBS Journal · doi:10.1111/febs.14985 · Cited by 90
Janković, B., Aquino‐Parsons, C., Raleigh, J. A., Stanbridge, E. J., Durand, R. E., Banáth, J. P., MacPhail, S. H., & Olive, P. L. (2006) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20086 · Cited by 87
Metadata
- Authors
- Hockel, M., & Vaupel, P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, P.
- ORCID
- Vaupel, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-21
- Volume
- 93
- Issue
- 4
- Pages
- 266-276
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2125257427
- Semantic Scholar
- 6c70b98add72efaae8670b5183983be403de59ae
- Cited by
- 2,662
- References
- 159
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 93 · 2023: 134 · 2022: 110 · 2021: 139 · 2020: 149 · 2019: 120 · 2018: 110 · 2017: 148 · 2016: 143 · 2015: 123 · 2014: 114 · 2013: 104 · 2012: 114
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tissue hypoxia, solid tumors, tumor microcirculation, oxygen partial pressure, tumor progression, treatment resistance, tumor physiology, oxygen diffusion
- MeSH terms
- Animals, Humans, Neoplasms, Oxygen, Predictive Value of Tests, Prognosis, Risk Factors, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review